Article

Five Dangers Of An Insecure API Supply Chain

Source: Pfizer CentreOne

By Ken Ball, Commercial Operations Lead, Pfizer CentreOne

iStock-1195574782-chain-link-weak-connection-supply

The diversity and agility of API supply chains are key to ensuring that medicines can be manufactured and delivered to patients on time, even in the face of challenges and unforeseen circumstances.

Ken Ball, Commercial Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses five dangers of an insecure API supply chain.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: